￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Ixazomib versus olverembatinib in chronic myeloid leukemia and multiple myeloma

2026-02-01 22:25:32

Check Details
Ixazomib combined with daratumumab and low-dose dexamethasone has limited efficacy in patients with moderate multiple myeloma

2026-02-01 22:25:32

Check Details
Must-read for patients: Overview of basic information in the instructions for use of ixazomib

2026-02-01 22:25:32

Check Details
Several things patients must know when taking the drug: What are the warnings and precautions for ixazomib?

2026-02-01 22:25:32

Check Details
Latest medical news: Is ixazomib on the market?

2026-02-01 22:25:32

Check Details
Latest medical news: Is it necessary to take ixazomib long-term?

2026-02-01 22:25:32

Check Details
Is ixazomi covered by medical insurance? What is the latest reimbursement policy?

2026-02-01 22:25:32

Check Details
Latest efficacy analysis: Taking ixazomib can prevent recurrence for several years

2026-02-01 22:25:32

Check Details
What are the side effects of Apelix?

2026-02-01 22:25:32

Check Details
What is the mechanism of action of Apelix? How does it work?

2026-02-01 22:25:32

Check Details
Correct usage and dosage of Apelix and how to use it?

2026-02-01 22:25:32

Check Details
Which company develops and produces Apelis?

2026-02-01 22:25:32

Check Details
Category
相关知识